
How Antibody-Drug Conjugates Have Impacted HER2-Positive Breast Cancer Treatment
Antibody-drug conjugates, or ADCs, have had a tremendous impact on the treatment of some types of breast cancer, according to Dr. Charles E. Geyer. Geyer is a professor of medicine at the University of Pittsburgh School of Medicine, UPMC Hillman Cancer …